相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chemiluminescence Immunoassay Method of Urinary Liver Fatty-acid-binding Protein as a Promising Candidate for Kidney Disease
Lisong Niu et al.
JOURNAL OF FLUORESCENCE (2023)
PPARγ Acetylation Orchestrates Adipose Plasticity and Metabolic Rhythms
Ying He et al.
ADVANCED SCIENCE (2023)
Menin-MLL1 Interaction Small Molecule Inhibitors: A Potential Therapeutic Strategy for Leukemia and Cancers
Qing Shi et al.
MOLECULES (2023)
Menin regulates lipid deposition in mouse hepatocytes via interacting with transcription factor FoxO1
Shengxuan Wang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2022)
Non-alcoholic fatty liver disease and type 2 diabetes: An update
Chi-H Lee et al.
JOURNAL OF DIABETES INVESTIGATION (2022)
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis
Adria Juanola et al.
JOURNAL OF HEPATOLOGY (2022)
GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease
Anja Baumann et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2022)
Current treatment of non-alcoholic fatty liver disease
Rafael Paternostro et al.
JOURNAL OF INTERNAL MEDICINE (2022)
Discovery of Novel, Potent, and Selective Small-Molecule Menin-Mixed Lineage Leukemia Interaction Inhibitors through Attempting Introduction of Hydrophilic Groups
Hao Lei et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
MEN1 deficiency leads to neuroendocrine differentiation of lung cancer and disrupts the DNA damage response
Huan Qiu et al.
NATURE COMMUNICATIONS (2020)
Men1 maintains exocrine pancreas homeostasis in response to inflammation and oncogenic stress
Amanda R. Wasylishen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2020)
Identification of Crucial Genetic Factors, Such as PPAR gamma, that Regulate the Pathogenesis of Fatty Liver Disease in Dairy Cows Is Imperative for the Sustainable Development of Dairy Industry
Kerong Shi et al.
ANIMALS (2020)
Protein acetylation in mitochondria plays critical functions in the pathogenesis of fatty liver disease
Le-tian Zhang et al.
BMC GENOMICS (2020)
Ets1-Mediated Acetylation of FoxO1 Is Critical for Gluconeogenesis Regulation during Feed-Fast Cycles
Kai Li et al.
CELL REPORTS (2019)
Heart-type fatty acid binding protein (H-FABP) as a biomarker for acute myocardial injury and long-term post-ischemic prognosis
Xiao-dong Ye et al.
ACTA PHARMACOLOGICA SINICA (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Novel Mechanism of Foxo1 Phosphorylation in Glucagon Signaling in Control of Glucose Homeostasis
Yuxin Wu et al.
DIABETES (2018)
MEN1/Menin regulates milk protein synthesis through mTOR signaling in mammary epithelial cells
Honghui Li et al.
SCIENTIFIC REPORTS (2017)
Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients
Soha Abd El Dayem et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2016)
Progranulin Stimulates Proliferation of Mouse Pancreatic Islet Cells and Is Overexpressed in the Endocrine Pancreatic Tissue of an MEN1 Mouse Model
Andreea Barbu et al.
PANCREAS (2016)
Tumor suppressor Menin acts as a corepressor of LXRα to inhibit hepatic lipogenesis
Peng Cheng et al.
FEBS LETTERS (2015)
Targeting β-catenin signaling for therapeutic intervention in MEN1-deficient pancreatic neuroendocrine tumours
Xiuli Jiang et al.
NATURE COMMUNICATIONS (2014)
Predictive Effects of Urinary Liver-Type Fatty Acid-Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
Shin-ichi Araki et al.
DIABETES CARE (2013)
The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators
Kerong Shi et al.
ENDOCRINE-RELATED CANCER (2013)
Hepatic menin recruits SIRT1 to control liver steatosis through histone deacetylation
Yanan Cao et al.
JOURNAL OF HEPATOLOGY (2013)
The tumor suppressor protein menin inhibits NF-κB-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma
Ding Gang et al.
MOLECULAR BIOLOGY REPORTS (2013)
Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription
Bin Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Inhibitors of Fatty Acid Synthesis Induce PPARα-Regulated Fatty Acid β-Oxidative Genes: Synergistic Roles of L-FABP and Glucose
Huan Huang et al.
PPAR RESEARCH (2013)
Glucose-Mediated Repression of Menin Promotes Pancreatic β-Cell Proliferation
Hongli Zhang et al.
ENDOCRINOLOGY (2012)
The same pocket in menin binds both MLL and JUND but has opposite effects on transcription
Jing Huang et al.
NATURE (2012)
Menin liver-specific hemizygous mice challenged with high fat diet show increased weight gain and markers of metabolic impairment
L. Wuescher et al.
NUTRITION & DIABETES (2012)
Insulin regulates menin expression, cytoplasmic localization, and interaction with FOXO1
Leah Wuescher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2011)
The Tumor Suppressor Protein Menin Inhibits AKT Activation by Regulating Its Cellular Localization
Yan Wang et al.
CANCER RESEARCH (2011)
Menin prevents liver steatosis through co-activation of peroxisome proliferator-activated receptor alpha
Peng Cheng et al.
FEBS LETTERS (2011)
Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance
Hitomi Imachi et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Lack of SIRT1 (Mammalian Sirtuin 1) Activity Leads to Liver Steatosis in the SIRT1(+/-) Mice: A Role of Lipid Mobilization and Inflammation
Fen Xu et al.
ENDOCRINOLOGY (2010)
The Multiple Endocrine Neoplasia Type 1 (MEN1) Tumor Suppressor Regulates Peroxisome Proliferator-Activated Receptor γ-Dependent Adipocyte Differentiation
Koen M. A. Dreijerink et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Nuclear-Cytoplasmic Shuttling of Menin Regulates Nuclear Translocation of β-Catenin
Yanan Cao et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Multiple endocrine neoplaslia type 1 (MEN 1): Analysis of 1336 mutations reported in the first decade following identification of the gene
Manuel C. Lemos et al.
HUMAN MUTATION (2008)
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Masato Furuhashi et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Menin controls growth of pancreatic β-cells in pregnant mice and promotes gestational diabetes mellitus
Satyajit K. Karnik et al.
SCIENCE (2007)
Wnt signaling regulates pancreatic β cell proliferation
Ingrid C. Rulifson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Aberrant forkhead box O1 function is associated with impaired hepatic metabolism
Shen Qu et al.
ENDOCRINOLOGY (2006)
Mutation of tumor suppressor gene menl acutely enhances proliferation of pancreatic islet cells
Robert W. Schnepp et al.
CANCER RESEARCH (2006)
Menin links estrogen receptor activation to histone H3K4 trimethylation
Koen M. A. Dreijerink et al.
CANCER RESEARCH (2006)
Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation
H Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
TA Milne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes
C Wolfrum et al.
NATURE (2004)
Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1
P Bertolino et al.
MOLECULAR ENDOCRINOLOGY (2003)
Genetic ablation of the tumor suppresor menin causes lethality at mid-gestation with defects in multiple organs
P Bertolino et al.
MECHANISMS OF DEVELOPMENT (2003)
Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1
A Poisson et al.
CANCER LETTERS (2003)
The multiple endocrine neoplasia type 1 gene product, menin, inhibits the human prolactin promoter activity
H. Namihira et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2002)
The tumor suppressor protein menin interacts with NF-κB proteins and inhibits NF-κB-mediated transactivation
C Heppner et al.
ONCOGENE (2001)
A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors
JS Crabtree et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
